$CORT attracted 6 mentions over the past 12 months from 2 distinct FinTwit voices, with the first mention appearing on 2026-02-05. @adamfeuerstein dominated discussion with 5 mentions, while @jacobplieth contributed 1 mention. Biotech-focused voices led commentary on the ticker. The most recent activity occurred on 2026-03-26 when discussions centered on Corcept Therapeutics' relacorilant approval for advanced ovarian cancer and the drug's labeling profile.